• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新提出的代谢评分对预测未来糖尿病的内脏脂肪的有用性:来自 NAGALA 队列研究的结果。

Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.

机构信息

Department of Endocrinology, Jiangxi Provincial People's Hospital, Medical College of Nanchang University, Nanchang, Jiangxi, China.

Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jul 19;14:1172323. doi: 10.3389/fendo.2023.1172323. eCollection 2023.

DOI:10.3389/fendo.2023.1172323
PMID:37538796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395081/
Abstract

OBJECTIVE

Visceral adipose tissue assessment holds significant importance in diabetes prevention. This study aimed to explore the association between the newly proposed Metabolic Score for Visceral Fat (METS-VF) and diabetes risk and to further assess the predictive power of the baseline METS-VF for the occurrence of diabetes in different future periods.

METHODS

This longitudinal cohort study included 15,464 subjects who underwent health screenings. The METS-VF, calculated using the formula developed by Bello-Chavolla et al., served as a surrogate marker for visceral fat obesity. The primary outcome of interest was the occurrence of diabetes during the follow-up period. Established multivariate Cox regression models and restricted cubic spline (RCS) regression models to assess the association between METS-VF and diabetes risk and its shape. Receiver operating characteristic (ROC) curves were used to compare the predictive power of METS-VF with body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and visceral adiposity index (VAI) for diabetes, and time-dependent ROC analysis was conducted to assess the predictive capability of METS-VF for the occurrence of diabetes in various future periods.

RESULTS

During a maximum follow-up period of 13 years, with a mean of 6.13 years, we observed that the cumulative risk of developing diabetes increased with increasing METS-VF quintiles. Multivariable-adjusted Cox regression analysis showed that each unit increase in METS-VF would increase the risk of diabetes by 68% (HR 1.68, 95% CI 1.13, 2.50), and further RCS regression analysis revealed a possible non-linear association between METS-VF and diabetes risk ( for non-linearity=0.002). In addition, after comparison by ROC analysis, we found that METS-VF had significantly higher predictive power for diabetes than other general/visceral adiposity indicators, and in time-dependent ROC analysis, we further considered the time-dependence of diabetes status and METS-VF and found that METS-VF had the highest predictive value for predicting medium- and long-term (6-10 years) diabetes risk.

CONCLUSION

METS-VF, a novel indicator for assessing visceral adiposity, showed a significantly positive correlation with diabetes risk. It proved to be a superior risk marker in predicting the future onset of diabetes compared to other general/visceral adiposity indicators, particularly in forecasting medium- and long-term diabetes risk.

摘要

目的

内脏脂肪组织评估在糖尿病预防中具有重要意义。本研究旨在探讨新提出的代谢评分用于评估内脏脂肪(METS-VF)与糖尿病风险的相关性,并进一步评估基线 METS-VF 对不同未来时期糖尿病发生的预测能力。

方法

这是一项纵向队列研究,纳入了 15464 名接受健康筛查的受试者。METS-VF 是使用 Bello-Chavolla 等人提出的公式计算得出的,作为内脏脂肪肥胖的替代标志物。主要结局是随访期间发生糖尿病。采用多变量 Cox 回归模型和限制性三次样条(RCS)回归模型评估 METS-VF 与糖尿病风险及其形态的关系。采用受试者工作特征(ROC)曲线比较 METS-VF 与体重指数(BMI)、腰围(WC)、腰高比(WHtR)和内脏脂肪指数(VAI)对糖尿病的预测能力,并进行时间依赖性 ROC 分析,以评估 METS-VF 对不同未来时期糖尿病发生的预测能力。

结果

在最长 13 年的随访期间(平均 6.13 年),我们观察到随着 METS-VF 五分位组的增加,发生糖尿病的累积风险增加。多变量调整的 Cox 回归分析显示,METS-VF 每增加一个单位,糖尿病的风险增加 68%(HR 1.68,95%CI 1.13,2.50),进一步的 RCS 回归分析显示 METS-VF 与糖尿病风险之间可能存在非线性关系( 非线性=0.002)。此外,通过 ROC 分析比较后发现,METS-VF 对糖尿病的预测能力明显高于其他一般/内脏脂肪指标,在时间依赖性 ROC 分析中,我们进一步考虑了糖尿病状态和 METS-VF 的时间依赖性,发现 METS-VF 对预测中-长期(6-10 年)糖尿病风险具有最高的预测价值。

结论

METS-VF 是一种新的评估内脏脂肪的指标,与糖尿病风险呈显著正相关。与其他一般/内脏脂肪指标相比,它在预测未来糖尿病发病方面具有更高的风险标志物价值,特别是在预测中-长期糖尿病风险方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/dd62ffb21537/fendo-14-1172323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/d1d9d6802e10/fendo-14-1172323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/320ac5dc67f7/fendo-14-1172323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/c69d8cb6c308/fendo-14-1172323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/dd62ffb21537/fendo-14-1172323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/d1d9d6802e10/fendo-14-1172323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/320ac5dc67f7/fendo-14-1172323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/c69d8cb6c308/fendo-14-1172323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc1/10395081/dd62ffb21537/fendo-14-1172323-g004.jpg

相似文献

1
Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.评估新提出的代谢评分对预测未来糖尿病的内脏脂肪的有用性:来自 NAGALA 队列研究的结果。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1172323. doi: 10.3389/fendo.2023.1172323. eCollection 2023.
2
Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study.内脏脂肪代谢评分与慢性肾脏病的关系:一项横断面研究。
Front Endocrinol (Lausanne). 2022 Dec 5;13:1052736. doi: 10.3389/fendo.2022.1052736. eCollection 2022.
3
Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.代谢性内脏脂肪评分:预测高血压风险的可靠内脏肥胖指标。
Nutrition. 2022 Jan;93:111443. doi: 10.1016/j.nut.2021.111443. Epub 2021 Aug 10.
4
Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study.中国成年人中预测代谢综合征及其组分风险的人体测量学指标比较:一项前瞻性纵向研究。
BMJ Open. 2017 Sep 18;7(9):e016062. doi: 10.1136/bmjopen-2017-016062.
5
Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.中国成年生长激素缺乏患者中各种身体指标和内脏脂肪指数对代谢综合征的预测敏感性
J Endocrinol Invest. 2017 Jun;40(6):653-661. doi: 10.1007/s40618-017-0621-2. Epub 2017 Feb 23.
6
Is Metabolic Score for Visceral Fat (METS-VF) a Better Index Than Other Adiposity Indices for the Prediction of Visceral Adiposity.内脏脂肪代谢评分(METS-VF)在预测内脏脂肪方面是否比其他肥胖指数是更好的指标?
Diabetes Metab Syndr Obes. 2023 Aug 29;16:2605-2615. doi: 10.2147/DMSO.S421623. eCollection 2023.
7
Metabolic Score for Visceral Fat: a novel predictor for the risk of type 2 diabetes mellitus.代谢性内脏脂肪评分:2 型糖尿病风险的新预测指标。
Br J Nutr. 2022 Sep 28;128(6):1029-1036. doi: 10.1017/S0007114521004116. Epub 2021 Oct 11.
8
Association of the visceral fat metabolic score with osteoarthritis risk: a cross-sectional study from NHANES 2009-2018.内脏脂肪代谢评分与骨关节炎风险的关联:来自 NHANES 2009-2018 的横断面研究。
BMC Public Health. 2024 Aug 21;24(1):2269. doi: 10.1186/s12889-024-19722-0.
9
Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).内脏脂肪指数(VAI)在肥胖儿童和青少年中的应用:与每日能量摄入无关,但有望成为识别代谢综合征(MetS)的工具。
Nutrients. 2021 Jan 28;13(2):413. doi: 10.3390/nu13020413.
10
Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk.内脏脂肪代谢评分(METS-VF):慢性肾脏病风险的一种新的预测替代指标。
Diabetes Metab Syndr Obes. 2022 Jul 29;15:2249-2258. doi: 10.2147/DMSO.S370222. eCollection 2022.

引用本文的文献

1
Association between metabolic score for visceral fat and psoriasis: findings from NHANES.内脏脂肪代谢评分与银屑病之间的关联:来自美国国家健康与营养检查调查(NHANES)的结果
Eur J Med Res. 2025 Aug 12;30(1):739. doi: 10.1186/s40001-025-03002-7.
2
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
3
Association of visceral fat metabolic score with bone mineral density and osteoporosis: a NHANES cross-sectional study.

本文引用的文献

1
Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study.内脏脂肪代谢评分与慢性肾脏病的关系:一项横断面研究。
Front Endocrinol (Lausanne). 2022 Dec 5;13:1052736. doi: 10.3389/fendo.2022.1052736. eCollection 2022.
2
Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study.新型血脂指标与中国高血压患者 2 型糖尿病发病风险的相关性研究:广州心脏研究。
Cardiovasc Diabetol. 2022 Oct 15;21(1):212. doi: 10.1186/s12933-022-01660-z.
3
Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk.
内脏脂肪代谢评分与骨密度及骨质疏松症的关联:一项美国国家健康与营养检查调查横断面研究
J Health Popul Nutr. 2025 May 14;44(1):156. doi: 10.1186/s41043-025-00914-2.
4
Correlation Between Metabolic Score for Visceral Fat and Cardiovascular-Kidney-Metabolic Syndrome: Analysis of NHANES 2011-2020.内脏脂肪代谢评分与心血管-肾脏-代谢综合征之间的相关性:2011 - 2020年美国国家健康与营养检查调查分析
Healthcare (Basel). 2025 Mar 21;13(7):694. doi: 10.3390/healthcare13070694.
5
Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease.内脏脂肪代谢评分与非酒精性脂肪性肝病患者的全因死亡率和心血管死亡率相关。
BMC Gastroenterol. 2025 Apr 10;25(1):238. doi: 10.1186/s12876-025-03833-y.
6
Comparison of the predictive value of 17 anthropometric in-dices for the prevalence of metabolic syndrome among Chinese residents: a cross-sectional study.17项人体测量指标对中国居民代谢综合征患病率预测价值的比较:一项横断面研究
Diabetol Metab Syndr. 2025 Apr 7;17(1):118. doi: 10.1186/s13098-025-01679-8.
7
Association of visceral fat metabolism score with risk of rheumatoid arthritis in US adults.美国成年人内脏脂肪代谢评分与类风湿关节炎风险的关联
Front Nutr. 2025 Mar 20;12:1544624. doi: 10.3389/fnut.2025.1544624. eCollection 2025.
8
Association of Metabolic Score for Visceral Fat (METS-VF) with Gout Risk in Patients with Hypertension and Hyperuricemia: A Multicenter Study Based on the Chinese Population.内脏脂肪代谢评分(METS-VF)与高血压合并高尿酸血症患者痛风风险的关联:一项基于中国人群的多中心研究。
Diabetes Metab Syndr Obes. 2025 Mar 12;18:761-779. doi: 10.2147/DMSO.S502675. eCollection 2025.
9
Association between metabolic visceral fat score and left ventricular hypertrophy in individuals with type 2 diabetes.2型糖尿病患者代谢性内脏脂肪评分与左心室肥厚之间的关联
Diabetol Metab Syndr. 2025 Mar 6;17(1):81. doi: 10.1186/s13098-025-01648-1.
10
Association of Cumulative Exposure to Metabolic Score for Visceral Fat With the Risk of Cardiovascular Disease and All-Cause Mortality: A Prospective Cohort Study.内脏脂肪代谢评分的累积暴露与心血管疾病风险及全因死亡率的关联:一项前瞻性队列研究
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13702. doi: 10.1002/jcsm.13702.
内脏脂肪代谢评分(METS-VF):慢性肾脏病风险的一种新的预测替代指标。
Diabetes Metab Syndr Obes. 2022 Jul 29;15:2249-2258. doi: 10.2147/DMSO.S370222. eCollection 2022.
4
Metabolic Score for Visceral Fat: a novel predictor for the risk of type 2 diabetes mellitus.代谢性内脏脂肪评分:2 型糖尿病风险的新预测指标。
Br J Nutr. 2022 Sep 28;128(6):1029-1036. doi: 10.1017/S0007114521004116. Epub 2021 Oct 11.
5
Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.代谢性内脏脂肪评分:预测高血压风险的可靠内脏肥胖指标。
Nutrition. 2022 Jan;93:111443. doi: 10.1016/j.nut.2021.111443. Epub 2021 Aug 10.
6
Genetic and Environmental Factors Contributing to Visceral Adiposity in Asian Populations.遗传和环境因素对亚洲人群内脏脂肪的影响。
Endocrinol Metab (Seoul). 2020 Dec;35(4):681-695. doi: 10.3803/EnM.2020.772. Epub 2020 Dec 23.
7
Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults.非肥胖成年人内脏脂肪代谢评分与高尿酸血症的纵向关联。
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1751-1757. doi: 10.1016/j.numecd.2020.06.001. Epub 2020 Jun 12.
8
Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference.腹型肥胖指标与糖尿病并发症的相关性:中国内脏脂肪指数和颈围。
Cardiovasc Diabetol. 2020 Jul 31;19(1):118. doi: 10.1186/s12933-020-01095-4.
9
Causes, consequences, and treatment of metabolically unhealthy fat distribution.代谢不健康的脂肪分布的原因、后果和治疗。
Lancet Diabetes Endocrinol. 2020 Jul;8(7):616-627. doi: 10.1016/S2213-8587(20)30110-8.
10
Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease.遗传学对内脏脂肪的影响及其与心血管和代谢疾病的关系。
Nat Med. 2019 Sep;25(9):1390-1395. doi: 10.1038/s41591-019-0563-7. Epub 2019 Sep 9.